SourceOne Stock Info  Your one source site for stock research

 

 

 

Company Website

Investor Relations

 

 

What’s the buzz—

message boards

Yahoo

Market Watch

Money Central

Raging Bull

Board Central

 

 

 

 

 

 

 

 

Valeant Pharmaceuticals International

 

VRX

Valeant Pharmaceuticals is a specialty pharmaceutical company that develops, manufactures and markets a selection of pharmaceutical products. The company focuses on the therapeutic areas of neurology, dermatology and infectious disease. Its products are sold in more than 100 markets through three pharmaceutical units: North America, International (composed of the Latin America, Asia and Australasia regions), and EMEA (Europe, Middle East and Africa). On October 4, 2006, the Company signed a distribution agreement with Intendis GmbH for rights to certain dermatology products in the United Kingdom. This agreement includes the distribution rights to Finacea, a topical treatment for rosacea.

 

Stock Quotes and Other Information

Nasdaq

NYSE

Msn

Yahoo

Silicon Investor

Excite

Lycos

Market Watch

Clear Station

StockHouse

 

SourceOne Message Board

 

Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name

 

 

 

 

 

 

 

 

 

 

 

 

 

S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35

 

Home